Clinical Germline Testing Results of Men With Prostate Cancer: Patient-Level Factors and Implications of NCCN Guideline Expansion

Samantha Greenberg,Trevor C. Hunt,Jacob P. Ambrose,William T. Lowrance,Christopher Dechet,Brock ONeil,Jonathan D. Tward

Clinical Germline Testing Results of Men With Prostate Cancer: Patient-Level Factors and Implications of NCCN Guideline Expansion

2021

Samantha Greenberg
Trevor C. Hunt
Jacob P. Ambrose
William T. Lowrance
Christopher Dechet
Brock ONeil
Jonathan D. Tward

PURPOSEGermline likely pathogenic or pathogenic variants (PVs) have been identified in up to 17% of men with prostate cancer (PC) and may drive disease severity or be targetable by novel therapies....

Keywords:

Prostate cancer
Internal medicine
Oncology
disease severity
Likely pathogenic
Medicine
Germline
Guideline

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations